Supervisory board

Georges has joined the Matisse Supervisory board in 2020.

Georges de Meris is an independent advisor and supervisor and holds multiple board positions at healthcare companies and non-profit associations.

He was advisor M&A, fraud & compliance and restructuring & finance at Joanknecht. He has been lawyer at Holla lawyers where he focused on corporate law and law relating to Financing, Securities and Insolvency. He is also officially a qualified mediator. Prior to this, Georges de Meris worked at Ernst & Young for 27 years, including as partner Corporate Finance. In addition, he has been active as interim director at Internal Audit, where he oversaw a merger of bank and insurer.

Georges de Meris holds degrees in Business Administration, Dutch Law, and is Registered Accountant and Chartered Accountant.

Bob has been the CEO of Matisse Pharmaceuticals from 2014 to 2022 before joining the Supervisory board in the beginning of 2023.

With an educational background in Pharmacy, Bob Kool started his career as pharmacy practitioner in his own pharmacies in Roermond. During this period he was active in the board of the Dutch pharmacist branch organisation (KNMP), section Limburg.

Bob was also member of the board of Regifarm, a pharmaceutical wholesale cooperation in Rotterdam, where he was involved in the establishment of a generics division. Together with Jacques Havermans he founded a generics company for the Regifarm Group. Kool worked as a consultant for Arcadis BMB SENTER projects as a pharmaceutical expert in designing and building a factory for the production of generics in Russia and Bulgaria. In 2003, Kool founded the Basic Pharma Group and implemented the business concept of combining pharmaceutical licensing, manufacturing, supply and services under one roof. Kool's main focus areas are Process & Product development, Business Development and Corporate Strategy.

Marcel joined the Matisse Supervisory board in 2017. He is currently Managing Partner of Brightlands Venture Partners with a fund size of € 125 mln. While acting as Investment Manager with DSM Venturing (a corporate VC), Marcel was asked in 2006 to support DSM’s regional VC activities in 2006  as senior investment manager of Limburg Ventures, while subsequently moving to the positions of director of Chemelot Ventures and director of BVP Fund IV. Since 2022 Marcel is fully operational for BVP. Marcel has been involved in a large number of investments , strategic sales and IPO’s where he is or has been acting as a board member and/or shareholder for multiple portfolio companies. His fields of interest and expertise span the areas of life sciences and cleantech. Before his involvement in venture capital, Marcel held various management functions within DSM in market research, emerging technologies, new business development and new business creation to lead assessor and corporate secretary. He has a PhD in organic chemistry from Leiden University (Netherlands).

Richard Holslag joined the Supervisory Board of Matisse in 2017. 

Richard is currently senior consultant at Emteka Consultancy, production manager at Biospring GmbH and Chairman of the board of Basic Pharma B.V. 

Previously he was Site Director and VP Manufacturing for BioMarin Nederland B.V. in Leiden, The Netherlands (former Prosensa Therapeutics BV). Richard furthermore worked as Sr. Director Industrialization for vaccine manufacturing in tech transfer projects in Asia for Crucell. Prior to this Richard was Site Manager for a flu vaccine factory in Quebec Canada, which in 3 years changed ownership from Shire Biologics, to ID Biomedical and finally became GSK. In Berna Biotech Ltd., Richard was EVP Industrialization involved in the strategic planning. As Sr.Director Operations for Rhein Biotech NV he implemented manufacturing projects in Argentina, Portugal, India and South-Korea. He held the CEO position of Green Cross Vaccine Corp. in South Korea after its acquisition by Rhein Biotech.

Before 1999 Richard was an independent quality and manufacturing consultant and he worked for 20 years in Gist Brocades bv, a company now owned by DSM. Richard started as a qualified process engineer, having obtained his Masters Degree at Delft University in 1976 and was involved in R&D project-management, know how transfer, re-organization project-management.